We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRA
6176
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4K ﹤0.01%
376
-155
-29% -$1.92K
LUB
6177
DELISTED
Luby's Inc.
LUB
$4K ﹤0.01%
3,026
VOLT
6178
DELISTED
Volt Information Sciences, Inc.
VOLT
$4K ﹤0.01%
3,300
-1,400
-30% -$1.3K
YGYI
6179
DELISTED
Youngevity International, Inc Common Stock
YGYI
$4K ﹤0.01%
2,630
+1,963
+294% +$3.05K
RHE
6180
DELISTED
Regional Health Properties, Inc.
RHE
$4K ﹤0.01%
+2,883
New +$3.71K
GSP
6181
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$4K ﹤0.01%
512
MCRO
6182
DELISTED
IQ Hedge Macro Tracker
MCRO
$4K ﹤0.01%
158
-62
-28% -$1.59K
ALAR
6183
Alarum Technologies
ALAR
$12.4M
$3K ﹤0.01%
185
+182
+6,067% +$2.56K
ASRV icon
6184
AmeriServ Financial
ASRV
$76.8M
$3K ﹤0.01%
836
-250
-23% -$729
BCH icon
6185
Banco de Chile
BCH
$21.1B
$3K ﹤0.01%
+172
New +$3.02K
BW icon
6186
Babcock & Wilcox
BW
$1.39B
$3K ﹤0.01%
1,303
-412
-24% -$711
CANE icon
6187
Teucrium Sugar Fund
CANE
$75M
$3K ﹤0.01%
542
MBAI
6188
Check-Cap
MBAI
$8.12M
$3K ﹤0.01%
260
CHPT icon
6189
ChargePoint
CHPT
$139M
$3K ﹤0.01%
15
-7
-32% -$1.38K
CLRB icon
6190
Cellectar Biosciences
CLRB
$20.2M
$3K ﹤0.01%
7
-34
-83% -$14.3K
CURI icon
6191
CuriosityStream
CURI
$143M
$3K ﹤0.01%
301
-189
-39% -$1.86K
EGY icon
6192
Vaalco Energy
EGY
$562M
$3K ﹤0.01%
1,771
-6,122
-78% -$6.15K
EURL icon
6193
Direxion Daily FTSE Europe Bull 3x ETF
EURL
$53.7M
$3K ﹤0.01%
220
-1,000
-82% -$13.3K
FISK
6194
Empire State Realty OP LP Series 250
FISK
$1.32B
$3K ﹤0.01%
300
FTRI icon
6195
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$123M
$3K ﹤0.01%
280
FVAL icon
6196
Fidelity Value Factor ETF
FVAL
$1.3B
$3K ﹤0.01%
100
GCMG icon
6197
GCM Grosvenor
GCMG
$749M
$3K ﹤0.01%
263
-268
-50% -$2.78K
GSM icon
6198
FerroAtlántica
GSM
$585M
$3K ﹤0.01%
6,222
+2,179
+54% +$1.3K
INDP icon
6199
Indaptus Therapeutics
INDP
$179M
$3K ﹤0.01%
5
-15
-75% -$9.27K
INTG icon
6200
InterGroup Corp
INTG
$58.2M
$3K ﹤0.01%
100
-1
-1% -$28

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.